Do adventitious viruses carried by insect cell lines producing AAV vectors pose a safety risk in gene therapy?

Haemophilia. 2018 Nov;24(6):843-844. doi: 10.1111/hae.13525. Epub 2018 May 31.

Author

R Kaczmarek^{1

2}

Affiliations

¹ Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
² Polish Hemophilia Society, Warsaw, Poland.

PMID: 29855117
DOI: 10.1111/hae.13525

No abstract available

MeSH terms

Adenoviridae / genetics
Animals
Cell Line
Genetic Therapy / methods*
Genetic Vectors / genetics
Hemophilia A / genetics
Hemophilia A / therapy*
Humans
Insect Viruses / genetics*
Insecta
Patient Safety
Risk
Virus Diseases / genetics*